- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ 30.0107 ↓ -1.56%
[as on 23 January, 2026]
NAV chart
SMA (Simple Moving Average)
Returns
| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|
| LIC MF Healthcare Fund-Direct Plan-Growth | -5.9% | -1.56% | -4.88% | -6.71% | -9.06% | -5.6% | - | - | - | - |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|
| 97.11% |
0.00% (Arbitrage: 0.00%) |
0.00% |
0.00% |
2.90% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 10.39% |
| Apollo Hospitals Enterprise Ltd. | APOLLOHOSP (INE437A01024) | Healthcare Services | 5.90% |
| Cipla Ltd. | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 5.35% |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 5.34% |
| Fortis Healthcare Ltd. | FORTIS (INE061F01013) | Healthcare Services | 4.92% |
| Divi's Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 4.74% |
| Neuland Laboratories Ltd. | NEULANDLAB (INE794A01010) | Pharmaceuticals & Biotechnology | 4.54% |
| Piramal Pharma Ltd. | PPLPHARMA (INE0DK501011) | Pharmaceuticals & Biotechnology | 4.52% |
| Aurobindo Pharma Ltd. | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 4.07% |
| Alkem Laboratories Ltd. | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 3.91% |
| Onesource Specialty Pharma Ltd. | ONESOURCE (INE013P01021) | Pharmaceuticals & Biotechnology | 3.59% |
| Abbott India Ltd. | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 3.20% |
| Navin Fluorine International Ltd. | NAVINFLUOR (INE048G01026) | Chemicals & Petrochemicals | 3.11% |
| Artemis Medicare Services Ltd. | ARTEMISMED (INE025R01021) | Healthcare Services | 3.08% |
| Gland Pharma Ltd. | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 2.94% |
| IPCA Laboratories Ltd. | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 2.66% |
| Glenmark Pharmaceuticals Ltd. | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 2.59% |
| Metropolis Healthcare Ltd. | METROPOLIS (INE112L01020) | Healthcare Services | 2.57% |
| Mankind Pharma Ltd. | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 2.33% |
| Dr Agarwal's Health Care Ltd. | AGARWALEYE (INE943P01029) | Healthcare Services | 2.29% |
| Global Health Ltd. | MEDANTA (INE474Q01031) | Healthcare Services | 2.24% |
| Max Healthcare Institute Ltd. | MAXHEALTH (INE027H01010) | Healthcare Services | 2.20% |
| Syngene International Ltd. | SYNGENE (INE398R01022) | Healthcare Services | 2.10% |
| Concord Biotech Ltd. | CONCORDBIO (INE338H01029) | Pharmaceuticals & Biotechnology | 2.03% |
| Acutaas Chemicals Ltd. | ACUTAAS (INE00FF01025) | Pharmaceuticals & Biotechnology | 1.92% |
| Anthem Biosciences Ltd. | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 1.86% |
| Vinati Organics Ltd. | VINATIORGA (INE410B01037) | Chemicals & Petrochemicals | 1.65% |
| Linde India Ltd. | LINDEINDIA (INE473A01011) | Chemicals & Petrochemicals | 1.07% |
Portfolio data is as on date 31 October, 2025
NAV (Net asset value) history
LIC MF Healthcare Fund-Direct Plan-Growth - 30 days NAV history
| Date | NAV |
|---|
| 23 January, 2026 | 30.0107 |
| 22 January, 2026 | 30.4874 |
| 21 January, 2026 | 30.2953 |
| 20 January, 2026 | 30.5267 |
| 19 January, 2026 | 31.2803 |
| 16 January, 2026 | 31.5514 |
| 14 January, 2026 | 31.8239 |
| 13 January, 2026 | 31.8537 |
| 12 January, 2026 | 31.8505 |
| 9 January, 2026 | 31.9239 |
| 8 January, 2026 | 32.2798 |
| 7 January, 2026 | 32.772 |
| 6 January, 2026 | 32.5111 |
| 5 January, 2026 | 32.1752 |
| 2 January, 2026 | 32.18 |
| 1 January, 2026 | 31.8933 |
| 31 December, 2025 | 31.9574 |
| 30 December, 2025 | 31.6818 |
| 29 December, 2025 | 31.7784 |
| 26 December, 2025 | 31.9287 |
| 24 December, 2025 | 32.0249 |
| 23 December, 2025 | 32.1686 |
| 22 December, 2025 | 32.1637 |
| 19 December, 2025 | 31.9859 |
| 18 December, 2025 | 31.6281 |
| 17 December, 2025 | 31.6738 |
| 16 December, 2025 | 31.8709 |
| 15 December, 2025 | 32.0826 |
| 12 December, 2025 | 32.1631 |
| 11 December, 2025 | 32.0617 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of LIC MF Healthcare Fund-Direct Plan-Growth?
The latest NAV of LIC MF Healthcare Fund-Direct Plan-Growth is 30.0107 as on 23 January, 2026.
What are YTD (year to date) returns of LIC MF Healthcare Fund-Direct Plan-Growth?
The YTD (year to date) returns of LIC MF Healthcare Fund-Direct Plan-Growth are -5.9% as on 23 January, 2026.
What are 1 year returns of LIC MF Healthcare Fund-Direct Plan-Growth?
The 1 year returns of LIC MF Healthcare Fund-Direct Plan-Growth are -5.6% as on 23 January, 2026.